Close

Immunogen, Inc. (IMGN) Tops Q4 Expectations

August 2, 2013 7:21 AM EDT
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $3.44 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings